Literature DB >> 29564748

Increasing FLAIR signal intensity in the postoperative cavity predicts progression in gross-total resected high-grade gliomas.

Guan-Min Quan1, Yong-Li Zheng2, Tao Yuan3, Jian-Ming Lei1.   

Abstract

To evaluate the prognostic value of fluid-attenuated inversion recovery (FLAIR) signal intensity of postoperative cavity on progression free survival (PFS) and overall survival (OS) in patients with high-grade gliomas (HGG). This study retrospectively enrolled 45 consecutive HGG patients. These patients had chemoradiotherapy after gross-total resection of tumors. Quantitative analysis of the FLAIR signal intensity in postoperative cavity and background was made. We evaluated the threshold value, accuracy, sensitivity, specificity, and survival state with this technique. The patients who progressed and patients who did not progress were 33 and 12 cases separately. The ratio of postoperative cavity and background (C-B) on FLAIR sequence in patients who progressed was higher than that of patients who did not progress (P = 0.014). The PFS of the patients who progressed was shorter than that of patients who did not progress (P = 0.008). The area under ROC curve, threshold, sensitivity, specificity of C-B ratio for predicting tumor progression were 0.875, 62.3, 69.7, 0.84, and 0.50% respectively. The PFS of lower signal group was much longer than that of higher signal group (P = 0.004). The OS of the patients with higher signal was shorter than that of patients with lower signal (P = 0.034). The increase of gray value of FLAIR in postoperative cavity may be used as an imaging marker for predicting tumor progression.

Entities:  

Keywords:  Chemoradiotherapy; FLAIR; Glioma; Magnetic resonance imaging; Outcome

Mesh:

Year:  2018        PMID: 29564748     DOI: 10.1007/s11060-018-2758-z

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  33 in total

1.  Prognostic Value of Dynamic Susceptibility Contrast-Enhanced and Diffusion-Weighted MR Imaging in Patients with Glioblastomas.

Authors:  G Çoban; S Mohan; F Kural; S Wang; D M O'Rourke; H Poptani
Journal:  AJNR Am J Neuroradiol       Date:  2015-04-02       Impact factor: 3.825

2.  Prognosis prediction of non-enhancing T2 high signal intensity lesions in glioblastoma patients after standard treatment: application of dynamic contrast-enhanced MR imaging.

Authors:  Rihyeon Kim; Seung Hong Choi; Tae Jin Yun; Soon-Tae Lee; Chul-Kee Park; Tae Min Kim; Ji-Hoon Kim; Sun-Won Park; Chul-Ho Sohn; Sung-Hye Park; Il Han Kim
Journal:  Eur Radiol       Date:  2016-06-29       Impact factor: 5.315

3.  Early post-operative magnetic resonance imaging in glioblastoma: correlation among radiological findings and overall survival in 60 patients.

Authors:  Carles Majós; Mònica Cos; Sara Castañer; Miguel Gil; Gerard Plans; Anna Lucas; Jordi Bruna; Carles Aguilera
Journal:  Eur Radiol       Date:  2015-07-19       Impact factor: 5.315

4.  Nonenhancing peritumoral hyperintense lesion on diffusion-weighted imaging in glioblastoma: a novel diagnostic and specific prognostic indicator.

Authors:  Manish Kolakshyapati; Rupendra B Adhikari; Vega Karlowee; Takeshi Takayasu; Ryo Nosaka; Vishwa J Amatya; Yukio Takeshima; Yuji Akiyama; Kazuhiko Sugiyama; Kaoru Kurisu; Fumiyuki Yamasaki
Journal:  J Neurosurg       Date:  2017-03-31       Impact factor: 5.115

5.  FLAIR signal increase of the fluid within the resection cavity after glioma surgery: generally valid as early recurrence marker?

Authors:  Stefanie Bette; Jens Gempt; Thomas Huber; Claire Delbridge; Bernhard Meyer; Claus Zimmer; Jan S Kirschke; Tobias Boeckh-Behrens
Journal:  J Neurosurg       Date:  2016-10-21       Impact factor: 5.115

6.  Comparison of Gadolinium Concentrations within Multiple Rat Organs after Intravenous Administration of Linear versus Macrocyclic Gadolinium Chelates.

Authors:  Robert J McDonald; Jennifer S McDonald; Daying Dai; Dana Schroeder; Mark E Jentoft; David L Murray; Ramanathan Kadirvel; Laurence J Eckel; David F Kallmes
Journal:  Radiology       Date:  2017-06-19       Impact factor: 11.105

7.  Pre- and Posttreatment Glioma: Comparison of Amide Proton Transfer Imaging with MR Spectroscopy for Biomarkers of Tumor Proliferation.

Authors:  Ji Eun Park; Ho Sung Kim; Kye Jin Park; Sang Joon Kim; Jeong Hoon Kim; Seth A Smith
Journal:  Radiology       Date:  2015-08-19       Impact factor: 11.105

8.  Fractional Anisotropy Correlates with Overall Survival in Glioblastoma.

Authors:  Thomas Huber; Stefanie Bette; Benedikt Wiestler; Jens Gempt; Julia Gerhardt; Claire Delbridge; Melanie Barz; Bernhard Meyer; Claus Zimmer; Jan S Kirschke
Journal:  World Neurosurg       Date:  2016-08-23       Impact factor: 2.104

9.  Prognostic Imaging Biomarkers in Glioblastoma: Development and Independent Validation on the Basis of Multiregion and Quantitative Analysis of MR Images.

Authors:  Yi Cui; Khin Khin Tha; Shunsuke Terasaka; Shigeru Yamaguchi; Jeff Wang; Kohsuke Kudo; Lei Xing; Hiroki Shirato; Ruijiang Li
Journal:  Radiology       Date:  2015-09-04       Impact factor: 11.105

10.  Post-radiation increase in VEGF enhances glioma cell motility in vitro.

Authors:  Whoon Jong Kil; Philip J Tofilon; Kevin Camphausen
Journal:  Radiat Oncol       Date:  2012-02-22       Impact factor: 3.481

View more
  2 in total

1.  Supratotal resection in glioma: a systematic review.

Authors:  Charles N de Leeuw; Michael A Vogelbaum
Journal:  Neuro Oncol       Date:  2019-02-14       Impact factor: 12.300

2.  Relative T2-FLAIR signal intensity surrounding residual cavity is associated with survival prognosis in patients with lower-grade gliomas.

Authors:  Tao Yuan; Zhen Gao; Fei Wang; Jia-Liang Ren; Tianda Wang; Hongbo Zhong; Guodong Gao; Guanmin Quan
Journal:  Front Oncol       Date:  2022-09-15       Impact factor: 5.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.